Pharm-Neuroendocrine-Melissa Flashcards

(55 cards)

1
Q

Release of the following hormones from the hypothalamus will induce/inhibit the release of which hormones from the anterior pituitary:
GHRH, CRH, TRH, GnRH, Dopamine

A
GHRH--> GH
CRH--> ACTH
TRH--> TSH, PRL 
GnRH--> FSH +LH
DA--> INHIBITON of PRL release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the two hormones released by the posterior pituitary?

A
  • oxytocin

- ADH/ vasopressin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the two negative feedback mechanisms imposed upon hypothalamic/ anterior pituitary system:

A

Target organ hormone–> Inhibit Pit + hypothalamus

Pit Hormone–> Inhibit hypothalamus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which two hypothalamic hormones regulate the release of GH from the anterior pituitary?
What is the function of GH?

A

GHRH–> ^ Release GH
Somatostatin –> INHIBIT Release GH

GH induces synthesis of IGF-1 which regulates growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do we treat hypothalamic dwarfism; what is deficient in the disease?
What are 4 CI’s for this method of treatment?

A

Hypothalamic dwarfism = Deficient GHRH
Treat with GH replacement (+ sex hormones at puberty)

CI for GH therapy:

  • closing epiphyses
  • over 15 yoa
  • Inability to make IGF-1 (Laron dwarfism)
  • active malignancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the GH preparations used to treat patients with hypothalamic dwarfism? (2)

A
  • Somatropin

- Sermorelin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Somatropin: what is the drug and what does it treat?

How is it administered?

A
  • Recombinant DNA match for human GH
  • Treats hypothalamic dwarfism etc.
  • Administer SQ 1x/ day
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Sermorelin: what is the drug and what does it treat?

A
  • Synthetic GHRH
  • Formerly used to treat hypothalamic dwarfism etc.
  • Fell out of favor bc not as effective as direct GH therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List all the uses for GH therapy (6):

A
  • hypothalamic dwarfism
  • turner’s syndrome
  • prader willi (without obesity or sleep apnea = DEATH)
  • chronic renal insufficiency
  • idiopathic short stature
  • AIDS waisting (anabolic effects)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Two ADRS associated with GH therapy:

A
  • ^ ICP early in treatment
  • diabetogenic effects
  • Note: kids generally tolerate treatment well
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Human recombinant IGF-1:
Therapeutic use (2)?
How is it administered?
ADRs (2)?

A

Treat growth problems assts with low IGF-1:

  • Laron dwarfism (GH-R mutations)
  • Pts with Abs against GH

Administer SQ 1-2x/day, preferably after meal to avoid hypoglycemia

ADRs:

  • Hypoglycemia
  • Lipohypertrophy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the problem with Laron Dwarfism?

A

Mutant GH-Rs–> Can not make IGF-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Excess GH: effects in adults and kiddos

A

Kiddos: gigantism
Adults: Acromegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are two somatostatin analogs used to treat ^GH in adults and kids? How do they work? ROA?

PAY ATTENTION TO SPECIAL NOTE REGARDING OCTREOTIDE ON OTHER SIDE OF THIS CARD. CAME FROM RX QUESTIONS!!!!

A

Octreotide + Lanreotide–>
Somatostatin analogs w longer t 1/2–>
INHIBIT GH secretion + DECREASE IGF-1

Administer SQ

–Special fact about octreotide: it inhibits gastric secretions and vasoconstricts: used to treat carcinoid syndrome!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some of the ADRs associated with Octreotide and Lanreotide?

A
  • GI PROBLEMS: N/V/D/ Abdominal pain

- Gall stones (Decrease biliary cntrxn, GI time)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is one possible alternative use for octreotide and lanreotide?

A

Treat thyrotrope adenomas because they decrease thyrotropin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Pegvisomant:

MOA, Therapeutic use, ROA, ADRs (2)

A

MOA:
Competitive GH-R ANTAGONIST–> DECREASE IGF-1
Tx: ^^^ GH
ROA: SQ
ADR: Lipohypertrophy at injection site, Hepatotoxic
**Monitor liver function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are 5 problems that can cause excessive prolactin release?

A
  • Hypothalamic lesion–> DECREASE DA
  • Antipsychotic DA-R antagonists
  • Prolactin secreting pituitary adenoma
  • Renal insufficiency (decrease breakdown prolactin)
  • Excess TRH (hypothyroidism)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the hallmark sx of hyperprolactinemia (4):

A
  • amenorrhea
  • infertility ***
  • impotence
  • galactorrhea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Cabergoline + Bromocriptine:

MOA, Therapeutic use, differences between drugs–which is preferred?

A

MOA: D1 + D2 AGNONISTS
Tx: Hyperprolactinemia

Differences:

  • Cabergoline = preferred drug, selective D2 + longer t1/2
  • Bromocriptine also indicated for acromegaly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

***ADRs asstd. with Cabergoline + Bromocriptine:

A
  • N/V/ Dizziness; LESS with cabergoline

- Valvular disease (cabergoline only)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which drug do we use to diagnose hypothyroidism?

How do we know if the problem is primary, secondary, or tertiary?

A

PROTIRELIN: synthetic TRH–> ^ TSH release

  • ^TSH–> ^ T3/T4 = Hypothalamic defect (tertiary)
  • NO ^TSH–> NO ^ T3/T4 = Pituitary defect (secondary)
  • ^ TSH–> NO ^ T3/T4 = Thyroid defect (primary)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Cosyntropin:

MOA, Therapeutic use

A

MOA: synthetic ACTH analog (^ cortisol release)
Tx: Dx primary vs secondary adrenal insufficiency

24
Q

Describe the mechanism of GnRH naturally and how that is manipulated by long acting GnRH agents:

A

Normal:
PULSITILE GnRH–> FSH + LH release–> ^ E/ P/ T

Long Acting Agents:
CONSTANT GnRH–> DECREASE # GnRH-R’s–>
DECREASE FSH + LH release–> DECREASE E/ P/ T

25
How does hCG work to ^ fertility?
mimics actions od LH--> | ^ female ovulation (LH surge) + ^ male external sexual development (^ T)
26
What are the indications for hCG therapeutic use? (2)
- stimulating ovulation in women | - threat male infertility and cryptorchidism
27
Menotropins (hMG) What are the active components in these drugs? What are the two therapeutic uses?
- Contain equal LH and FSH - treats female infertility (^ follicular dvlpmt.) - ^ male spermatogenesis
28
Urofollitropin: What is the active component of this drug? What are the two therapeutic uses?
- Menotropin with most of LH removed; ^ FSH - treats female infertility (^ follicular dvlpmt.) - ^ male spermatogenesis
29
What are the gonadotropin mimicking drugs (2)? | What is their MOA and what are they used to treat?
Follitropin beta + alpha (recombinant FSH) - use like urofollitropin ``` Choriogonadotropin alpha (recombinant LH) - use like hCG ```
30
What are some ADRs associated with gonadotroipins? (3)
- multiple births - ovarian hyperstimulation syndrome - gynecomastia (^E)
31
What is ovarian hyper stimulation syndrome?
Leaky ovarian capillaries cause fluid to fill abdominal cavity --> painful abdomen
32
**Chlomiphene: MOA Therapeutic uses ADRS
MOA: Estrogen receptor ANTAGONIST--> INHIBIT E negative feedback to hypothalamus--> ^ LH + ^ FSH--> ^ fertility Therapeutic uses: - Infertility due to ovulatory disorder i.e. PCOS ADRs: - multiple births - antiestrogenic effects (endometrium, ovarian cysts, developing follicle)
33
Gonadorelin: MOA, therapeutic use?
- Synthetic GnRH - Administered via pump--> ^ endogenous FSH +LH - Treats infertility in females
34
Leuprolide, Goserelin, Nafarelin, Histrelin: | MOA, Dosing regimine?
Long acting Synthetic GnRH AGONIST MOA: DOWNREGULATES GnRH-R + INHIBIT GnRH Secretion Dosing: Admin continuously for 2-4 weeks
35
``` Leuprolide, Goserelin, Nafarelin, Histrelin: Therapeutic uses (4)? ```
Long acting Synthetic GnRH AGONIST - Endometriosis - Uterine fibroids - Prostate and breast cancers - Precocious puberty
36
Leuprolide, Goserelin, Nafarelin, Histrelin: ADRs?
Long acting Synthetic GnRH AGONIST: Problems with too low E and T... (like in menopause) 1. Hot flashes, vaginal atrophy 2. osteoporosis 3. erectile dysfunction
37
Flutamide + Bicalutamide: | MOA, Therapeutic use
MOA: Androgen receptor ANTAGONISTS Therapeutic use: * **Combo treatment with long acting GnRH analogs - Treats metastatic prostate disease
38
Why should Flutamide + Bicalutamide not be administered alone?
^ LH synthesis due to DECREASED testosterone mediated negative feedback--would ultimately lead to INCREASE in Testosterone production
39
Flutamide + Bicalutamide: ADRs
BLACK BOX: Reversible Hepatotoxicity; check liver function prior to use
40
Finasteride: | MOA, Therapeutic use?
MOA: 5-a reductase inhibitor; STOP T--> DHT Therapeutic use: BPH, prostate cancer, male pattern baldness
41
Describe the difference between central and nephrogentic DI-- How are the two diagnosed?
Central: inadequate ADH - synthetic vasopressin = INCREASE urine osmolality Nephrogentic: Kidneys fail to repsond to ADH - synthetic vasopressin NO EFFECT ON urine osmolality
42
What are two HIGH yield causes of nephrogenic DI?
LITHIUM + Dimiclocyclin!!
43
What are the symptoms of DI (both types)?
- polyuria and polydipsia | - dilute urine
44
Desmopressin: | MOA (3), therapeutic use (3)?
MOA: - Exogenous vasopressin w REDUCED (V1) vasopressor activity and INCREASED (V2) antidiuretic effects - ^ factor VIII - ^ VWF Therapeutic use: - CENTRAL DI - von Willibrand disease type1 - primary nocturnal enuresis
45
What are 3 of the ADRs associated with vasopressive therapy; with which drug are they worse?
- Facial pallor - ^GI motility (N/Cramping) - OVERSTIMULATION of V2 receptors--> H2O toxicity **Note that ADRs are worse with vasopressin than desmopressin
46
***How do Lithium and Demeclocycline cause nephrogenic DI?
Lithium + Demeclocycline--> INHIBIT V2-Rs in collecting duct! 1/3 of all patients on lithium will get this!!!
47
How do we treat/ prevent lithium induced nephrogenic DI? | What is the MOA here?
Administer AMILORIDE--> | BLOCKS Li+ uptake at the Na+ channel in the collecting duct--> reverse/ inhibit V2 effects
48
Amiloride: therapeutic use?
Treat nephrogenic DI induced by Lithium
49
What are three treatments used for nephrogenic DI?
- ^ H2O intake - Administer THIAZIDE diuretics - Na+ restriction
50
What is SIADH/ how does it present? | What 4 drug causes?
^^^ ADH--> hyoposmolality and hyponatremia Patients present with lethargy, N/V, cramping, convulsion, death 4 drug causes: - SSRI - TCA - Sulfadrugs - vinka alkaloids
51
Which tetracycline antibiotic is used to treat SIADH and how does it work?
Demeclocycline--> Inhibits vasopressin actions on collecting duct
52
What are the two vaptan drugs? | How do they work and what do they treat?
Conivaptan (V1 + V2 ANTAGONIST) Tolvaptan (V2 ANTAGONIST) Therapeutic Use: Euvolemic and hypervolemic hyponatremia asstd. with SIADH
53
What are the three methods used to treat SIADH?
- fluid restriction +/- hypertonic saline +/- loop diuretics - demeclocycline - vaptans
54
What are the therapeutic uses for pharmacologic oxytocin (4)? Describe the ROA for each use.
- abortion - induction of labor (IV) - postpartum hemorrhage (IM) - induction of lactation (intranasal)
55
What are 2 ADRs associated with synthetic oxytocin use?
- excessive uterine contraction--> harm mom and newborn | - water intoxication due to ^ resorption (has ADH effects)